Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

Press releases published on October 5, 2026

Oct. 5, 2026

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Oct. 5, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 

Indeterminate GlobeNewswire

Oct. 5, 2026

Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

Indeterminate GlobeNewswire

Oct. 5, 2026

Aldebaran Reports 1,728.9 m of 0.45% CuEq (0.41% Cu, 0.03 g/t Au & 1.34 g/t Ag), including 756 m of 0.68% CuEq (0.61% Cu, 0.03 g/t Au & 2.12 g/t Ag) at the Altar Copper-Gold Project in San Juan, Argentina

Indeterminate GlobeNewswire

Oct. 5, 2026

Satellos Granted Composition of Matter Patent for Forazapadin

Indeterminate GlobeNewswire

Oct. 5, 2026

Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

Indeterminate GlobeNewswire

Oct. 5, 2026

Iridex Completes Relocation of Manufacturing Facility to San Jose, California

Indeterminate GlobeNewswire

Oct. 5, 2026

AIMS Surpasses 185,000 Global Active Traders, Solidifying Its Position as a Leading Regulated Prime Broker

Indeterminate GlobeNewswire

Oct. 5, 2026

Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine

Indeterminate GlobeNewswire

Oct. 5, 2026

DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads

Indeterminate GlobeNewswire

Oct. 5, 2026

BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth

Indeterminate GlobeNewswire

Oct. 5, 2026

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

Indeterminate GlobeNewswire

Oct. 5, 2026

Harrow Closes Acquisition of TYRVAYA®

Indeterminate GlobeNewswire

Oct. 5, 2026

Electra Appoints General Manager to Lead Cobalt Refinery Commissioning and Operations

Indeterminate GlobeNewswire

Oct. 5, 2026

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Indeterminate GlobeNewswire

Oct. 5, 2026

VisionWave Outlines Development of Autonomous Defense Ecosystem Across Tactical UAV and Counter-UAS Applications

Indeterminate GlobeNewswire

Oct. 5, 2026

Patrick Tsang Brings Empulser to AIBotics in Definitive Defense-Technology Transaction

Indeterminate GlobeNewswire

Oct. 5, 2026

New Pico Laser for Tattoo Removal Includes Installation, On-Site Training and a Two-Year Warranty That Covers Technician Travel

Indeterminate GlobeNewswire

Oct. 5, 2026

Baker Hughes Signs Two Agreements to Develop Venezuela's Natural Gas and Energy Infrastructure

Indeterminate GlobeNewswire